What are the potential negative side effects of Ambien (zolpidem) in older adults or those with a history of substance abuse?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Negative Side Effects of Ambien (Zolpidem)

Ambien carries serious risks including complex sleep behaviors (sleep-driving, sleep-walking), falls and fractures, cognitive impairment, and increased mortality, with particularly high risks in older adults and those with substance abuse history who should generally avoid this medication. 1, 2

Most Serious and Life-Threatening Adverse Effects

Complex Sleep Behaviors

  • Sleep-driving, sleep-walking, and engaging in activities while not fully awake can occur after the first or any subsequent dose, potentially resulting in serious injury or death. 1
  • Other complex behaviors include preparing food, making phone calls, or having sex without memory of these events. 1
  • These behaviors can occur at recommended doses, even without alcohol or other CNS depressants. 1
  • The FDA mandates immediate discontinuation if complex sleep behaviors occur. 1

Falls, Fractures, and Physical Injuries

  • Zolpidem increases fracture risk with an adjusted odds ratio of 1.72 (95% CI 1.37-2.16). 2
  • Hip fractures specifically show a relative risk of 1.92 (95% CI 1.65-2.24). 3
  • Major head injuries or fractures requiring hospitalization have an adjusted hazard ratio of 1.67 (95% CI 1.19-2.34). 2
  • Hospitalized patients face a 4.28-fold increased risk of falls (P <0.001). 3

Cognitive and Psychiatric Effects

  • Memory impairment, psychiatric adverse events, depression, and anxiety occur at higher rates with long-term use according to FDA medical reviews. 4
  • Older patients experience a 5-fold increase in memory loss, confusion, and disorientation compared to placebo. 2, 4
  • A 3-fold increase in dizziness, loss of balance, or falls occurs in elderly patients. 2, 4
  • Hallucinations were reported in 7% of pediatric patients (versus 0% with placebo). 1

Mortality and Cancer Risk

  • Anxiolytic and hypnotic drugs including zolpidem are associated with increased all-cause mortality in observational data from the UK General Practice Research Database. 2, 4
  • Some studies show association with incident cancers, though evidence is inconsistent. 2

Common Adverse Effects

Next-Day Impairment

  • The FDA specifically warns about impaired driving the morning after use, with women experiencing slower drug clearance and greater next-day impairment than men. 1
  • Risk increases if taken with less than 7-8 hours of sleep remaining, at higher than recommended doses, or with other CNS depressants. 1
  • Common CNS effects include drowsiness, prolonged reaction time, dizziness, sleepiness, blurred/double vision, and reduced alertness. 1

Dose-Dependent Effects

  • Withdrawals due to adverse effects occur more frequently with zolpidem than placebo (6% versus 3%). 2
  • In elderly patients, 80.8% of adverse drug reactions were CNS-related including confusion, dizziness, and daytime sleepiness. 3

High-Risk Populations Requiring Special Caution

Older Adults

  • The American Geriatrics Society recommends avoiding benzodiazepine-like GABA receptor hypnotics including zolpidem in older adults due to sedation, cognitive impairment, and unsafe mobility with injurious falls. 2, 4
  • The recommended dose in elderly patients is 5 mg (not 10 mg) to minimize adverse effects. 1
  • In non-U.S. trials, 93% of patients reporting falls were ≥70 years old, with 82% taking doses >10 mg. 1

Women

  • Women clear zolpidem 45% slower than men, resulting in higher blood levels and greater risk of next-day impairment. 1
  • The FDA-recommended initial dose for women is 5 mg (versus 5-10 mg for men). 1
  • Women had higher mean plasma concentrations than men after 8 hours (28 vs. 20 ng/mL for 10mg IR). 3

Patients with Substance Abuse History

  • Zolpidem can lead to tolerance, abuse, and dependence despite initial claims of low abuse potential. 5
  • Withdrawal seizures have been reported, occurring at daily dosages as low as 160 mg/day but more commonly at 450-600 mg/day. 3, 5
  • One case report documented a patient escalating from normal dosing to 450 mg/day over five years, developing tolerance, abuse, dependence, and withdrawal seizures. 5

Pregnant and Breastfeeding Women

  • Limited postmarketing reports describe severe to moderate respiratory depression in neonates requiring artificial ventilation or intubation. 1
  • Increased incidence of low birth weight (OR 1.39), preterm delivery (OR 1.49), small for gestational age babies (OR 1.34), and cesarean deliveries (OR 1.74). 3
  • Zolpidem is present in breast milk and can cause excess sedation, hypotonia, and respiratory depression in infants. 1

Patients with Depression

  • Worsening of depression and suicidal thoughts/actions (including completed suicides) have been reported in depressed patients taking sedative-hypnotics. 1
  • Suicide attempts and completion are significantly linked with zolpidem use (OR 2.08; 95% CI 1.83-2.63) regardless of comorbid psychiatric illness. 3

Tolerance and Withdrawal Effects

Loss of Efficacy

  • Long-term trials show zolpidem was not statistically significantly different from placebo for sleep onset latency, total sleep time, or wake after sleep onset, indicating loss of efficacy with continued use. 4

Rebound Insomnia

  • Sleep onset latency significantly increased on the first night after stopping zolpidem (13.0 minutes; 95% CI 4.3-21.7; P<0.01). 3
  • However, most evidence suggests minimal rebound insomnia when used as recommended. 6, 7

Critical Prescribing Pitfalls to Avoid

  • Never prescribe doses exceeding 10 mg in men or 5 mg in women due to increased risk of next-day impairment and complex sleep behaviors. 8, 1
  • Avoid use in patients with severe hepatic impairment as it may contribute to encephalopathy. 1
  • Do not combine with other CNS depressants (benzodiazepines, opioids, alcohol) without dosage adjustments due to additive effects. 1
  • Zolpidem should only be used for short-term treatment (≤4 weeks) to minimize dependency and adverse effects. 8, 7
  • If discontinuing after prolonged use, taper gradually rather than abrupt cessation to minimize withdrawal symptoms. 8
  • Ensure patients have a full 7-8 hours available for sleep before taking zolpidem. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Zolpidem: Efficacy and Side Effects for Insomnia.

Health psychology research, 2021

Guideline

Long-Term Risks and Alternatives to Zolpidem

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Escitalopram and Zolpidem Combination Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.